Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study
PaperCitations, authors & open-access status
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 802 citations, 2018 year and hybrid oa status.
802
Citations
2018
Year
hybrid
OA Status